MINNESOTA CANCER SURVEILLANCE SYSTEM
Reportable List – Reporting Requirements (Minnesota Rules 4606.3302)
All malignancies with a behavior code of /2 or /3 as listed in the ICD-O 3rd Edition (except those specifically excluded on pg. 3), all benign and borderline brain and CNS
neoplasms, and all malignancies listed in the SEER Hematopoietic and Lymphoid Neoplasm Database. (Also refer to the Multiple Primary and Histology Coding Rules and
the Hematopoietic and Lymphoid Neoplasm Database when determining reportability.) Diagnoses include, but are not limited to the following:
Acoustic neuroma
Acute panmyelosis
Adamantinoma of long bones
Adenocarcinofibroma
Agnogenic myeloid metaplasia
AIN III
Askin tumor
Atypical teratoid/rhabdoid tumor
Blastoma
Carcinofibroma
Carcinoid (except ECL nos, strumal, tubular)
Carcinoma, all types (except basal cell and
squamous cell of non-genital skin)
Chordoma
Craniopharyngioma
Cystic Pancreatic endocrine neoplasm
Desmoplastic small round cell tumor
Dysgerminoma
Ectomesenchymoma
Endodermal sinus tumor
Endolymphatic stromal myosis
Endometrial stromatosis
Epitheloid trophoblastic tumor
Epithelioma, certain types (except basal cell and
squamous cell of non-genital skin)
Ewing tumor
Germ cell tumor
Germinoma
Heavy chain disease
Hepatoblastoma
Hepatoma, embryonal, malignant, NOS
Histiocytosis, malignant, disseminated or
generalized Langerhans cell, X
Hodgkin disease
Hutchinson melanotic freckle
Hypereosinophilic syndrome
Hypernephroma
Immunoproliferative disease, NOS; small intestinal
disease
Kaposi sarcoma
Klatskin tumor
Krukenberg tumor
Laryngeal intraepithelial neoplasia III (LIN III)
Letterer-Siwe disease
Linitis plastica
Lymphomatous polyposis, malignant
Lymphoproliferative disease of childhood, systemic
EBV positive T-cell
Lymphoproliferative disorder, chronic of NK cells;
primary cutaneous; post-transplant
polymorphic
Malignant tumor, all types (except malignant
hydatidiform mole)
Mast cell disease
Medulloepithelioma
Melanoma, all types (except juvenile)
Mesodermal mixed tumor
Mesothelioma (except cystic or benign)
Mullerian mixed tumor
Mycosis fungoides/pagetoid reticulosis
Myeloproliferative disease/disorder
Myelosclerosis
Nephroblastoma
Neuroblastoma
Neuroectodermal tumor (except melanotic)
Non-invasive mucinous cystic neoplasm of
pancreas
Paget disease (except bone)
Pancreatoblastoma
Pineal gland, all tumors
Pituitary gland, all tumors
Plasmacytoma
Polyembryoma
Precancerous melanosis, malignant melanoma in
situ
Pseudomyxoma peritonei
Queyrat erythroplasia
Rhabdoid tumor
Sarcoma, all types
Schwannoma, malignant and/or CNS
Seminoma
Sertoli-Leydig cell tumor, poorly differentiated or
sarcomatoid
Sezary syndrome/disease
Solid pseudopapillary neoplasm of pancreas
Spindle epithelial tumor with thymus-like element
Spinal cord, all tumors
VAIN III/VIN III/VUIN III
Wilms tumor
Yolk sac tumor
Reporting Requirements (Minnesota Rules 4606.3302)
•
•
•
•
•
•
Malignant and in situ neoplasms of all sites listed in ICD-O-3 with behavior code of /2 or /3, except as noted in next section
Basal and squamous cell carcinomas of the genitalia
All brain and central nervous system (CNS) neoplasms regardless of malignancy
Myeloproliferative and myelodysplastic disorders 2001 and later listed in ICD-O-3
Hematopoietic/lymphoid malignancies 2010 and later listed in the SEER Hematopoietic and Lymphoid Neoplasm Database
With or without microscopic confirmation
Diagnoses that are NOT reportable
•
•
•
•
•
Intraepithelial neoplasia of cervix (CIN III) diagnosed before 1992 or after 1995
Intraepithelial neoplasia of prostate (PIN III)
(Adeno)carcinoma in situ of the uterine cervix after 1995
Basal and squamous cell carcinoma of the skin (except genitalia)
Borderline ovarian tumors diagnosed before 1992 or after 2000
List of Common Reportable Acronyms
AIN
BALT
CASTLE
CPNET
DCIS
GISS
GIST
LCIS
LIN
MALT
MPNST
PNET
PPNET
RA
RAEB
RAEB-T
RARS
SALT
SETTLE
VIN/VAIN
VUIN
Anal intraepithelial neoplasia (III only)
Bronchial-associated lymphoid tissue
Carcinoma showing thymus-like element
Central primitive neuroectodermal tumor
Ductal carcinoma in situ
Gastrointestinal stromal sarcoma
Gastrointestinal stromal tumor
Lobular carcinoma in situ
Laryngeal intraepithelial neoplasia (III only)
Mucosa-associated lymphoid tissue
Malignant peripheral nerve sheath tumor
Qualifier List and Ambiguous Terminology
Reportable Qualifiers/Ambiguous Terms
Apparently/Appears to
Comparable/Compatible/Consistent with
Favors
Features/Foci of
Malignant appearing
Most Likely
Primitive neuroectodermal tumor
Peripheral primitive neuroectodermal tumor
Refractory anemia
Refractory anemia with excess blasts
Refractory anemia with excess blasts in transformation
Refractory anemia with ringed sideroblasts
Skin-associated lymphoid tissue
Spindle epithelial neoplasia (III only)
Vulvar/Vaginal intraepithelial neoplasia (III only)
Vulvar intraepithelial neoplasia (III only)
Presumed
Probably/Probable
Suspected
Suspicious (histology, peripheral
smear)
Typical of
Not Reportable Qualifiers/Ambiguous Terms
Approaching
Borderline
Cannot be ruled out
Equivocal
Possible
Potentially malignant
Questionable
Rule Out
Suggests
Suspicious but not diagnostic of
Suspicious (cytology)
Very close to
Worrisome